CareTech Share Forecast, Price & News

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CareTech in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" CareTech stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CTH, but not buy additional shares or sell existing shares.
View analyst ratings for CareTech or view top-rated stocks.

1 brokers have issued 1 year price targets for CareTech's shares. Their CTH stock forecasts range from GBX 750 to GBX 750. On average, they anticipate CareTech's stock price to reach GBX 750 in the next twelve months. This suggests a possible upside of 1.1% from the stock's current price.
View analysts' price targets for CareTech or view top-rated stocks among Wall Street analysts.

CareTech's stock was trading at GBX 576 at the beginning of the year. Since then, CTH stock has increased by 28.8% and is now trading at GBX 741.86.
View the best growth stocks for 2022 here.

CareTech declared a dividend on Wednesday, December 7th. Investors of record on Thursday, March 3rd will be given a dividend of GBX 9.50 per share on Wednesday, May 4th. This represents a dividend yield of 1.64%. The ex-dividend date is Thursday, March 3rd. This is a boost from CareTech's previous dividend of GBX 4.60. The official announcement can be accessed at this link.
View CareTech's dividend history.

CareTech(LON:CTH) pays an annual dividend of GBX 0.14 per share and currently has a dividend yield of 1.90%. The dividend payout ratio of CareTech is 201.43%. Payout ratios above 75% are not desirable because they may not be sustainable.
View CareTech's dividend history.

Some companies that are related to CareTech include Mediclinic International (MDC), RHÖN-KLINIKUM Aktiengesellschaft (RHK), Spire Healthcare Group (SPI), CENTRIC HEALTH (CHH), Georgia Healthcare Group PLC (GHG.L) (GHG), Totally (TLY), Assure (IOM), BLVD Centers (CXV), Venn Life Sciences (VENN), Widecells Group (WDC), Agility Health (AHI), Brain Resource (BRC), Cambian Group (CMBN), Champion Pain Care (CPAI) and Encompass Health (EHC).
View all of CTH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other CareTech investors own include Cambian Group (CMBN), Sound Energy (SOU), Telford Homes (TEF), Adtalem Global Education (ATGE), Advanced Computer Software Group (ASW), ASOS (ASC), Arcontech Group (ARC), Alliance Pharma (APH), Global X FTSE Andean 40 ETF (AND) and Animalcare Group (ANCR).

CareTech trades on the London Stock Exchange (LON) under the ticker symbol "CTH."

Shares of CTH and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of CTH stock can currently be purchased for approximately GBX 741.86.

CareTech (LON:CTH) has a market capitalization of £840.79 million and generates £495.40 million in revenue each year.

CareTech employs 11,000 workers across the globe.

CareTech's mailing address is Metropolitan House, 3 Darkes Lane, POTTERS BAR, EN6 1AG, United Kingdom. The official website for CareTech is www.caretech-uk.com. The company can be reached via phone at +44-1707-601800.